Clinical Trial Update: Transcranial Photobiomodulation for Bipolar Depression [NA]

View source ↗

Summary

This clinical trial update indicates that a study on transcranial photobiomodulation for bipolar depression (sponsored by Vielight Inc.) is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Snippet

Sponsor: Vielight Inc. | Conditions: Bipolar, Bipolar Disorder (BD) | NA | Status: NOT_YET_RECRUITING